MetaCap

Alcon Inc. Company Profile

NYSE: ALCHealth CareOphthalmic GoodsUSD

63.13+0.13 (+0.21%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Alcon at a glance

Alcon Inc. (NYSE: ALC) is a Ophthalmic Goods company in the Health Care sector headquartered in Geneva, TX, Switzerland. Alcon is led by Mr. David J. Endicott and employs about 25,000 people. The company's shares have traded publicly since 2019.

At a market capitalization of $30.52 billion, it is considered a large-cap company. Its SEC Central Index Key (CIK) is 0001167379, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Alcon do?

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Business description based on the company's public filings.

Company information

Legal name
Alcon Inc.
Ticker
NYSE: ALC
Industry
Ophthalmic Goods
CEO
Mr. David J. Endicott
Employees
25,000
Headquarters
Chemin de Blandonnet 8, Geneva, TX, Switzerland
Phone
41 589 112 110
Website
alcon.com
IPO year
2019
Market cap
$30.52B
SEC CIK
0001167379

Companies similar to Alcon

ALC peer companies
CompanyPrice% ChgMarket capCompare
COOThe Cooper Companies Inc.54.30-0.82%$10.33Bvs ALC
BLCOBausch + Lomb Corporation17.15-1.10%$6.13Bvs ALC
WRBYWarby Parker Inc. Class A24.95-1.42%$3.08Bvs ALC
EYENational Vision Holdings Inc.16.74-0.48%$1.32Bvs ALC
STAASTAAR Surgical Company22.38+0.09%$1.12Bvs ALC
RXSTRxSight Inc.4.85+1.04%$201.73Mvs ALC

Related